Evidence map›Paper›PMID 34155213›Full record

ArticleNature communications2021

A gain-of-function single nucleotide variant creates a new promoter which acts as an orientation-dependent enhancer-blocker.

Yavor K Bozhilov, Damien J Downes, Jelena Telenius, A Marieke Oudelaar, Emmanuel N Olivier, Joanne C Mountford, Jim R Hughes, Richard J Gibbons, Douglas R Higgs

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. A point mutation in thePhysiology and molecular biology of plants : an international journal of functional plant biology · 2024
    Article
  9. Article
  10. Article
  11. Enhancer-gene specificity in development and disease.Development (Cambridge, England) · 2022
    Review
  12. Erythroid Cell Research: 3D Chromatin, Transcription Factors and Beyond.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Yavor K BozhilovMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-3249-7245
Damien J DownesMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-5034-0869
Jelena TeleniusMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
A Marieke OudelaarThe Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Emmanuel N OlivierAlbert Einstein College of Medicine, Department of Cell Biology, New York, NY, USA.ORCID 0000-0001-9288-1746
Joanne C MountfordInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Jim R HughesMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-8955-7256
Richard J GibbonsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. richard.gibbons@ndcls.ox.ac.uk.
Douglas R HiggsMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. doug.higgs@imm.ox.ac.uk.ORCID 0000-0003-3579-8705
University of Oxford · GBAlbert Einstein College of Medicine · USMax Planck Institute for Biophysical Chemistry · DEUniversity of Glasgow · GB

Funding

Medical Research Council MC_UU_00016/14Medical Research Council MC_UU_00016/3Medical Research Council MC_UU_00016/4Medical Research Council MC_UU_12009Medical Research Council MC_UU_12009/15
6 · The paper itself

Abstract

Many single nucleotide variants (SNVs) associated with human traits and genetic diseases are thought to alter the activity of existing regulatory elements. Some SNVs may also create entirely new regulatory elements which change gene expression, but the mechanism by which they do so is largely unknown. Here we show that a single base change in an otherwise unremarkable region of the human α-globin cluster creates an entirely new promoter and an associated unidirectional transcript. This SNV downregulates α-globin expression causing α-thalassaemia. Of note, the new promoter lying between the α-globin genes and their associated super-enhancer disrupts their interaction in an orientation-dependent manner. Together these observations show how both the order and orientation of the fundamental elements of the genome determine patterns of gene expression and support the concept that active genes may act to disrupt enhancer-promoter interactions in mammals as in Drosophila. Finally, these findings should prompt others to fully evaluate SNVs lying outside of known regulatory elements as causing changes in gene expression by creating new regulatory elements.

Indexed as

alpha-Globinsalpha-ThalassemiaEnhancer Elements, GeneticGain of Function MutationGene Expression RegulationHumansMultigene FamilyPoint MutationPromoter Regions, GeneticTranscription, Geneticalpha-Globins

Identifiers

PMID34155213
PMCPMC8217497
OpenAlexW3176549757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.